Kim V. Narry, director of the Center for RNA Research of the Institute for Basic Science and chair professor at the ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

South Korean researchers have, for the first time in the world, uncovered how messenger ribonucleic acid (mRNA) vaccines ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, ...

Vaccine stocks have been under significant pressure since the FDA's top vaccine official resigned. Seeking Alpha analysts ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 ...

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate immune system. These mechanisms could enhance the body's ability to defend ...

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...